(LHX) L3Harris Technologies - Ratings and Ratios

L3Harris Technologies, Inc. (NYSE:LHX) is a global leader in providing advanced technology solutions for government and commercial sectors. The company operates through four key segments: Space & Airborne Systems (SAS), Integrated Mission Systems (IMS), Communication Systems (CS), and Aerojet Rocketdyne (AR). Each segment specializes in distinct areas, contributing to the companys comprehensive portfolio.

The SAS segment excels in satellite payloads and space-based sensors, supporting national security and space exploration. IMS focuses on ISR systems and autonomous technologies, enhancing situational awareness and mission efficiency. The CS segment delivers cutting-edge communication solutions, including tactical radios and night vision systems, crucial for defense and public safety. Aerojet Rocketdyne leads in propulsion systems, driving advancements in hypersonic and space missions.

Originally known as Harris Corporation, L3Harris was formed in 2019 through a merger, bringing over a century of expertise since its founding in 1895. Headquartered in Melbourne, Florida, the company is a pivotal player in defense and aerospace innovation. For more information, visit their website at https://www.l3harris.com.

Ticker Symbol: LHX
Exchange: NYSE
Type: Common Stock
Country Origin: United States
GICS Sub Industry: Aerospace & Defense

Average Volume 20d: 1,220,544
Last Price: $218.22
SMA 20: $211.91
SMA 50: $208.27
SMA 200: $224.31
ATR: 6.31

Market Cap: $37,929.89M USD
P/E: 25.71
P/E Forward: 18.73
P/B: 1.94
P/S: 1.76
RoE: 7.70%

3-Month Forecast: L3Harris Technologies is expected to show resilience, supported by its diverse segments and strong market position. Technically, the stock may test the SMA 200 resistance near $224, with potential to break higher if momentum continues. The ATR of 6.31 indicates manageable volatility. Fundamentally, the lower forward P/E of 18.73 suggests investor confidence in future growth, driven by defense spending and innovation leadership. Price targets may range between $220 and $230, with potential upside driven by earnings surprises and contract wins.